Mynosys Cellular Devices raises $25m from Decheng Capital
Mynosys Cellular Devices, which manufactures the Zepto cataract surgery device, has secured $25 million in a funding round led by investment firm Decheng Capital. The ... Read More
Alcon launches PanOptix trifocal intraocular lens for cataract patients in US
Alcon has commercially launched AcrySof IQ PanOptix trifocal intraocular lens (IOL) in the US after its approval by the US Food and Drug Administration (FDA). ... Read More